IONQ vs TRMB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
IONQ exhibits a critically weak financial health profile with a Piotroski F-Score of 1/9, indicating severe fundamental instability despite explosive revenue growth. While the company maintains a strong liquidity position (Current Ratio 15.50) and negligible debt, its valuation is disconnected from current performance, evidenced by an extreme Price/Sales ratio of 121.48. The disconnect between the 'Strong Buy' analyst consensus and the bearish insider selling/technical trend suggests a speculative bubble driven by quantum computing hype rather than fiscal viability.
Trimble Inc. presents a stark contrast between deterministic health metrics and analyst optimism. The Piotroski F-Score of 3/9 indicates weak financial health, and the current price of $69.50 trades at a significant premium to both the Graham Number ($31.29) and the Intrinsic Value ($51.92). While the company shows impressive earnings growth (80.50% YoY) and strong gross margins, stagnant revenue growth and bearish insider activity suggest caution. The stock is currently priced for a recovery that is not yet fully supported by the fundamental health scorecard.
Compare Another Pair
Related Comparisons
IONQ vs TRMB: Head-to-Head Comparison
This page compares IonQ, Inc. (IONQ) and Trimble Inc. (TRMB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.